Saskia Middeldorp

ORCID: 0000-0002-1006-6420 · 3 papers in corpus
other 2023
ESHRE guideline: recurrent pregnancy loss: an update in 2022
Human reproduction open ·doi:10.1093/hropen/hoad002

STUDY QUESTION: What are the updates for the recommended management of women with recurrent pregnancy loss (RPL) based on the best available evidence in the literature from 2017 to 2022? SUMMARY ANSWER: The guideline development group (GDG…

letter 2022
Risk of venous thromboembolism in women with endometriosis
Thrombosis research ·doi:10.1016/j.thromres.2022.07.014
2021
Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high- and low-dose rivaroxaban with aspirin.
Research and practice in thrombosis and haemostasis ·doi:10.1002/rth2.12474

BackgroundRivaroxaban may induce heavy menstrual bleeding. It is unknown if this effect is dose related or if rivaroxaban is associated with more menstrual bleeding than aspirin.ObjectivesTo demonstrate and compare menstrual patterns and ac…